Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (39)
Pravil Pokharel, Sabin Dhakal & Charles M. Dozois. (2023) The Diversity of Escherichia coli Pathotypes and Vaccination Strategies against This Versatile Bacterial Pathogen. Microorganisms 11:2, pages 344.
Crossref
Crossref
Namrata Baruah, Nadim Ahamad, Prolay Halder, Hemanta Koley & Dhirendra S. Katti. (2023) Facile synthesis of multi-faceted, biomimetic and cross-protective nanoparticle-based vaccines for drug-resistant Shigella: a flexible platform technology. Journal of Nanobiotechnology 21:1.
Crossref
Crossref
Namrata Baruah, Prolay Halder, Hemanta Koley & Dhirendra S. Katti. (2022) Stable Recombinant Invasion Plasmid Antigen C (IpaC)-Based Single Dose Nanovaccine for Shigellosis. Molecular Pharmaceutics 19:11, pages 3884-3893.
Crossref
Crossref
Parag Palit, Farhana Tasnim Chowdhury, Namrata Baruah, Bonoshree Sarkar, Sadia Noor Mou, Mehnaz Kamal, Towfida Jahan Siddiqua, Zannatun Noor & Tahmeed Ahmed. (2022) A Comprehensive Computational Investigation into the Conserved Virulent Proteins of Shigella species Unveils Potential Small-Interfering RNA Candidates as a New Therapeutic Strategy against Shigellosis. Molecules 27:6, pages 1936.
Crossref
Crossref
Muhammad Qasim, Marius Wrage, Björn Nüse & Jochen Mattner. (2022) Shigella Outer Membrane Vesicles as Promising Targets for Vaccination. International Journal of Molecular Sciences 23:2, pages 994.
Crossref
Crossref
Namrata Baruah, Nadim Ahamad, Suhrid Maiti, Debaki R. Howlader, Ushasi Bhaumik, Vinod V. Patil, Manoj K. Chakrabarti, Hemanta Koley & Dhirendra S. Katti. (2021) Development of a Self-Adjuvanting, Cross-Protective, Stable Intranasal Recombinant Vaccine for Shigellosis. ACS Infectious Diseases 7:12, pages 3182-3196.
Crossref
Crossref
Vanessa Arato, Davide Oldrini, Luisa Massai, Gianmarco Gasperini, Francesca Necchi & Francesca Micoli. (2021) Impact of O-Acetylation on S. flexneri 1b and 2a O-Antigen Immunogenicity in Mice. Microorganisms 9:11, pages 2360.
Crossref
Crossref
Francesco Citiulo, Francesca Necchi, Francesca Mancini, Omar Rossi, Maria Grazia Aruta, Gianmarco Gasperini, Renzo Alfini, Simona Rondini, Francesca Micoli, Rino Rappuoli, Allan Saul & Laura B. Martin. (2021) Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes. PLOS Neglected Tropical Diseases 15:10, pages e0009826.
Crossref
Crossref
Richard Walker, Robert W. Kaminski, Chad Porter, Robert K. M. Choy, Jessica A. White, James M. Fleckenstein, Fred Cassels & Louis Bourgeois. (2021) Vaccines for Protecting Infants from Bacterial Causes of Diarrheal Disease. Microorganisms 9:7, pages 1382.
Crossref
Crossref
Ada Kazi, Che Muhammad Khairul Hisyam Ismail, Amy Amilda Anthony, Candy Chuah, Chiuan Herng Leow, Boon Huat Lim, Kirnpal Kaur Banga Singh & Chiuan Yee Leow. (2020) Designing and evaluation of an antibody-targeted chimeric recombinant vaccine encoding Shigella flexneri outer membrane antigens. Infection, Genetics and Evolution 80, pages 104176.
Crossref
Crossref
Farhad Gilavand, Abdolrazagh Marzban, Gholamhossein Ebrahimipour, Neda Soleimani & Mehdi Goudarzi. (2020) Designation of chitosan nano-vaccine based on MxiH antigen of Shigella flexneri with increased immunization capacity. Carbohydrate Polymers 232, pages 115813.
Crossref
Crossref
Divya Hosangadi, Peter G. Smith & Birgitte K. Giersing. (2019) Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy. Vaccine 37:50, pages 7372-7380.
Crossref
Crossref
Mohammad Mehdi Adibzadeh Sereshgi, Meghdad Abdollahpour-Alitappeh, Mehdi Mahdavi, Reza Ranjbar, Kazem Ahmadi, Ramezan Ali Taheri & Mahdi Fasihi-Ramandi. (2019) Immunologic balance of regulatory T cell/T helper 17 responses in gastrointestinal infectious diseases: Role of miRNAs. Microbial Pathogenesis 131, pages 135-143.
Crossref
Crossref
Odile Launay, Augustin G. W. Ndiaye, Valentino Conti, Pierre Loulergue, Antonella Silvia Sciré, Anais Maugard Landre, Pietro Ferruzzi, Naouel Nedjaai, Lena Dorothee Schütte, Joachim Auerbach, Elisa Marchetti, Allan Saul, Laura B. Martin & Audino Podda. (2019) Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial. Frontiers in Immunology 10.
Crossref
Crossref
Min Jung Kim, Young-hye Moon, Heejoo Kim, Semi Rho, Young Kee Shin, Manki Song, Richard Walker, Cecil Czerkinsky, Dong Wook Kim & Jae-Ouk Kim. (2018) Cross-Protective Shigella Whole-Cell Vaccine With a Truncated O-Polysaccharide Chain. Frontiers in Microbiology 9.
Crossref
Crossref
M.S. Riddle, W.H. Chen, C.D. Kirkwood & C.A. MacLennan. (2018) Update on vaccines for enteric pathogens. Clinical Microbiology and Infection 24:10, pages 1039-1045.
Crossref
Crossref
Christina W. Obiero, Augustin G. W. Ndiaye, Antonella Silvia Sciré, Bonface M. Kaunyangi, Elisa Marchetti, Ann M. Gone, Lena Dorothee Schütte, Daniele Riccucci, Joachim Auerbach, Allan Saul, Laura B. Martin, Philip Bejon, Patricia Njuguna & Audino Podda. (2017) A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country. Frontiers in Immunology 8.
Crossref
Crossref
Odile Launay, David J.M. Lewis, Alessandra Anemona, Pierre Loulergue, Jo Leahy, Antonella Silvia Sciré, Anaïs Maugard, Elisa Marchetti, Stefano Zancan, Zhiming Huo, Simona Rondini, Rachid Marhaba, Oretta Finco, Laura B. Martin, Jochen Auerbach, Daniel Cohen, Allan Saul, Christiane Gerke & Audino Podda. (2017) Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe. EBioMedicine 22, pages 164-172.
Crossref
Crossref
D.P. Muthuirulandi Sethuvel, N.K. Devanga Ragupathi, S. Anandan & B. Veeraraghavan. (2017)
Update on:
Shigella
new serogroups/serotypes and their antimicrobial resistance
. Letters in Applied Microbiology 64:1, pages 8-18.
Crossref
Crossref
Claire Jenkins, Rob J. Rentenaar, Luce Landraud & Sylvain Brisse. 2017. Infectious Diseases. Infectious Diseases
1565
1578.e2
.
Yuchen Fan & James J. Moon. (2016) Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens. WIREs Nanomedicine and Nanobiotechnology 9:1.
Crossref
Crossref
Wilbur H. Chen & Karen L. Kotloff. (2016) Shigella Vaccine Development: Finding the Path of Least Resistance. Clinical and Vaccine Immunology 23:12, pages 904-907.
Crossref
Crossref
Mark S. Riddle, Robert W. Kaminski, Claudio Di Paolo, Chad K. Porter, Ramiro L. Gutierrez, Kristen A. Clarkson, Hailey E. Weerts, Christopher Duplessis, Amy Castellano, Cristina Alaimo, Kristopher Paolino, Robert Gormley & Veronica Gambillara Fonck. (2016) Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study. Clinical and Vaccine Immunology 23:12, pages 908-917.
Crossref
Crossref
Luna S. Joffe, Leonardo Nimrichter, Marcio L. Rodrigues & Maurizio Del Poeta. (2016) Potential Roles of Fungal Extracellular Vesicles during Infection. mSphere 1:4.
Crossref
Crossref
Sachin Mani, Thomas Wierzba & Richard I. Walker. (2016) Status of vaccine research and development for Shigella. Vaccine 34:26, pages 2887-2894.
Crossref
Crossref
Shahram Shokrian Hajibehzad, Hosein Honari, Jaber Nasiri, Fariba Abooei Mehrizi & Houshang Alizadeh. (2016) High-level transient expression of the N-terminal domain of IpaD from Shigella dysenteriae in four plant species transformed with different construct configurations. In Vitro Cellular & Developmental Biology - Plant 52:3, pages 293-302.
Crossref
Crossref
Rasha Y. Mahmoud, Daniel Henry Stones, Wenqin Li, Mohamed Emara, Ramadan A. El-domany, Depu Wang, Yili Wang, Anne Marie Krachler & Jun Yu. (2016)
The Multivalent Adhesion Molecule SSO1327 plays a key role in
Shigella sonnei
pathogenesis
. Molecular Microbiology 99:4, pages 658-673.
Crossref
Crossref
Corinne N. Thompson, Le Thi Phuong Tu, Katherine L. Anders, Nguyen Trong Hieu, Lu Lan Vi, Nguyen Van Vinh Chau, Vu Thuy Duong, Nguyen Ngoc Minh Chau, Tran Thi Hong Chau, Ha Thanh Tuyen, Tran Vu Thieu Nga, Pham Van Minh, Tran Do Hoang Nhu, Le Thi Quynh Nhi, Allan Saul, Laura B. Martin, Audino Podda, Christiane Gerke, Guy Thwaites, Cameron P. Simmons & Stephen Baker. (2016) The transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infants. Vaccine 34:6, pages 783-790.
Crossref
Crossref
Li-ying Wen, Ke-fu Zhao, Jian Cheng, Xu Wang, Hui-hui Yang, Ke-sheng Li, Zhi-wei Xu & Hong Su. (2015) The association between diurnal temperature range and childhood bacillary dysentery. International Journal of Biometeorology 60:2, pages 269-276.
Crossref
Crossref
Richard I. Walker. (2015) An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children. Vaccine 33:8, pages 954-965.
Crossref
Crossref
Soumik Barman, Hemanta Koley, Dhrubajyoti Nag, Sumio Shinoda, Gopinath Balakrish Nair & Yoshifumi Takeda. (2014) Passive immunity with multi-serotype heat-killed Shigellae in neonatal mice. Microbiology and Immunology 58:8, pages 463-466.
Crossref
Crossref
Wilmara Salgado-Pabón, Christoph Konradt, Philippe J. Sansonetti & Armelle Phalipon. (2014) New insights into the crosstalk between Shigella and T lymphocytes. Trends in Microbiology 22:4, pages 192-198.
Crossref
Crossref
Anna Brotcke Zumsteg, Christian Goosmann, Volker Brinkmann, Renato Morona & Arturo Zychlinsky. (2014) IcsA Is a Shigella flexneri Adhesin Regulated by the Type III Secretion System and Required for Pathogenesis. Cell Host & Microbe 15:4, pages 435-445.
Crossref
Crossref
R. W. Kaminski, M. Wu, K. R. Turbyfill, K. Clarkson, B. Tai, A. L. Bourgeois, L. L. Van De Verg, R. I. Walker & E. V. Oaks. (2014) Development and Preclinical Evaluation of a Trivalent, Formalin-Inactivated Shigella Whole-Cell Vaccine. Clinical and Vaccine Immunology 21:3, pages 366-382.
Crossref
Crossref
Francisco J. Martinez-Becerra, Xiaotong Chen, Nicholas E. Dickenson, Shyamal P. Choudhari, Kelly Harrison, John D. Clements, William D. Picking, Lillian L. Van De Verg, Richard I. Walker & Wendy L. Picking. (2013) Characterization of a Novel Fusion Protein from IpaB and IpaD of Shigella spp. and Its Potential as a Pan-Shigella Vaccine. Infection and Immunity 81:12, pages 4470-4477.
Crossref
Crossref
Soumik Barman, Hemanta Koley, Thandavarayan Ramamurthy, Manoj Kumar Chakrabarti, Sumio Shinoda, Gopinath Balakrish Nair & Yoshifumi Takeda. (2013)
Protective immunity by oral immunization with heat-killed
Shigella
strains in a guinea pig colitis model
. Microbiology and Immunology 57:11, pages 762-771.
Crossref
Crossref
Matthew A. Croxen, Robyn J. Law, Roland Scholz, Kristie M. Keeney, Marta Wlodarska & B. Brett Finlay. (2013) Recent Advances in Understanding Enteric Pathogenic Escherichia coli. Clinical Microbiology Reviews 26:4, pages 822-880.
Crossref
Crossref
Shai Ashkenazi & Dani Cohen. (2013)
An update on vaccines against
Shigella
. Therapeutic Advances in Vaccines 1:3, pages 113-123.
Crossref
Crossref
Anthony D. Rusden, David P. Stephenson & Naresh K. Verma. (2013)
Topological Investigation of Glucosyltransferase V in
Shigella flexneri
using the Substituted Cysteine Accessibility Method
. Biochemistry 52:15, pages 2655-2661.
Crossref
Crossref